| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046125587 |
| P356 | DOI | 10.1038/GENE.2009.58 |
| P932 | PMC publication ID | 2873233 |
| P698 | PubMed publication ID | 19693088 |
| P5875 | ResearchGate publication ID | 26753698 |
| P50 | author | Steven M. Wolinsky | Q45517979 |
| Tanmoy Bhattacharya | Q55414889 | ||
| Henry A. Erlich | Q110157647 | ||
| P2093 | author name string | J Phair | |
| E Trachtenberg | |||
| M Ladner | |||
| P2860 | cites work | Genome-wide associations of gene expression variation in humans | Q21145274 |
| HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage | Q28138607 | ||
| A whole-genome association study of major determinants for host control of HIV-1 | Q29614891 | ||
| High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles | Q33282995 | ||
| HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles | Q33382373 | ||
| Host genetic determinants of human immunodeficiency virus infection and disease progression in children | Q33575664 | ||
| Advantage of rare HLA supertype in HIV disease progression | Q34207773 | ||
| Genetic correlates of protection against HIV infection: the ally within | Q37354258 | ||
| The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors | Q43582696 | ||
| Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection | Q82808222 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 673-677 | |
| P577 | publication date | 2009-08-20 | |
| P1433 | published in | Genes and Immunity | Q15745246 |
| P1476 | title | The HLA-B/-C haplotype block contains major determinants for host control of HIV | |
| P478 | volume | 10 |
| Q44495895 | An Additive Effect of Protective Host Genetic Factors Correlates With HIV Nonprogression Status |
| Q21092450 | Common genetic variation and the control of HIV-1 in humans |
| Q42213787 | Development of multiplex pyrosequencing for HLA-B*57:01 screening using single nucleotide polymorphism haplotype |
| Q41993901 | Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches. |
| Q49232096 | Genome-wide scan for commons SNPs affecting bovine leukemia virus infection level in dairy cattle. |
| Q38952775 | HIV and host immunogenetics: unraveling the role of HLA-C. |
| Q36395847 | HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues. |
| Q30429923 | HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium |
| Q42284873 | HLA-G/C, miRNAs, and their role in HIV infection and replication |
| Q33828507 | Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers |
| Q34118186 | Pharmacogenetics of drug hypersensitivity |
| Q34742690 | Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression |
| Q34430206 | Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition |
| Q34040744 | Ring finger protein 39 genetic variants associate with HIV-1 plasma viral loads and its replication in cell culture |
| Q36997351 | Variants in ZNRD1 gene predict HIV-1/AIDS disease progression in a Han Chinese population in Taiwan |
Search more.